Tumor-free survival of 7 years after gene therapy for recurrent glioblastoma.
Floeth
Frank-Willi
FW
Department of Neurosurgery, Heinrich Heine University, Düsseldorf, Germany. floethf@uni-duesseldorf.de
Langen
Karl Josef
KJ
Reifenberger
Guido
G
Weber
Friedrich
F
D000328:Adult; D003399:Craniotomy; D018572:Disease-Free Survival; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005500:Follow-Up Studies; D005625:Frontal Lobe; D015774:Ganciclovir / Q000627:therapeutic use; D015316:Genetic Therapy; D005909:Glioblastoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D010296:Parietal Lobe; D018714:Radiotherapy, Adjuvant; D011993:Recombinant Fusion Proteins / Q000037:antagonists & inhibitors; D012074:Remission Induction; D012086:Reoperation; D016879:Salvage Therapy; D015173:Supratentorial Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D017741:Survivors; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors / Q000235:genetics
D004791:Enzyme Inhibitors; D011993:Recombinant Fusion Proteins; D013937:Thymidine Kinase; D015774:Ganciclovir